Gateway 2012: Metrics, Inc. - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Gateway 2012: Metrics, Inc.


Metrics, Inc.
MetricsInc.com
1240 Sugg Parkway, Greenville, NC 27834

Contact Information:
Jeff Basham, VP Sales & Marketing
jeff@metricsinc.com or 252-752-3800

Metrics Inc. is one of the most respected CDMOs in the US today. Our full range of services includes formulations development, commercial manufacturing, analytical methods development, First Time In Man, potent and cytotoxic drug handling, raw materials testing, trace metals testing and stability storage and testing.

Three critical differences set Metrics apart. One, clients work directly with a senior Metrics pharmaceutical scientist or analytical development chemist. Two, projects are expedited quickly and efficiently; they don’t languish in an analytical development queue, so timelines are met consistently. Three, Metrics’ quality assurance team is highly experienced, ensuring compliance with all regulatory issues.


Metrics is pleased to invite you to visit our booth #1119 at Interphex. To meet our team please contact Jeff Basham, VP of Sales and Marketing, at jeff@metricsinc.com or 252-752-3800.


Metrics Capabilities Brochure

Metrics Analytical Services

Metrics Potent Products

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
8%
All of the above.
46%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing

Click here